1. Home
  2. STIM vs BGX Comparison

STIM vs BGX Comparison

Compare STIM & BGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STIM
  • BGX
  • Stock Information
  • Founded
  • STIM 2003
  • BGX 2010
  • Country
  • STIM United States
  • BGX United States
  • Employees
  • STIM N/A
  • BGX N/A
  • Industry
  • STIM Medical/Dental Instruments
  • BGX Trusts Except Educational Religious and Charitable
  • Sector
  • STIM Health Care
  • BGX Finance
  • Exchange
  • STIM Nasdaq
  • BGX Nasdaq
  • Market Cap
  • STIM 192.0M
  • BGX 162.5M
  • IPO Year
  • STIM 2018
  • BGX N/A
  • Fundamental
  • Price
  • STIM $4.13
  • BGX $12.82
  • Analyst Decision
  • STIM Buy
  • BGX
  • Analyst Count
  • STIM 4
  • BGX 0
  • Target Price
  • STIM $4.67
  • BGX N/A
  • AVG Volume (30 Days)
  • STIM 2.1M
  • BGX 67.9K
  • Earning Date
  • STIM 03-04-2025
  • BGX 01-01-0001
  • Dividend Yield
  • STIM N/A
  • BGX 10.34%
  • EPS Growth
  • STIM N/A
  • BGX N/A
  • EPS
  • STIM N/A
  • BGX N/A
  • Revenue
  • STIM $72,711,000.00
  • BGX N/A
  • Revenue This Year
  • STIM $3.23
  • BGX N/A
  • Revenue Next Year
  • STIM $29.55
  • BGX N/A
  • P/E Ratio
  • STIM N/A
  • BGX N/A
  • Revenue Growth
  • STIM 5.03
  • BGX N/A
  • 52 Week Low
  • STIM $0.52
  • BGX $10.69
  • 52 Week High
  • STIM $5.07
  • BGX $12.44
  • Technical
  • Relative Strength Index (RSI)
  • STIM 59.06
  • BGX 47.27
  • Support Level
  • STIM $2.80
  • BGX $12.80
  • Resistance Level
  • STIM $5.03
  • BGX $12.95
  • Average True Range (ATR)
  • STIM 0.49
  • BGX 0.13
  • MACD
  • STIM 0.04
  • BGX -0.01
  • Stochastic Oscillator
  • STIM 59.64
  • BGX 20.00

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

About BGX Blackstone Long Short Credit Income Fund

Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It seeks to achieve its investment objectives by employing a dynamic long-short strategy in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first- and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.

Share on Social Networks: